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ABSTRACT 
Dysfunction in adipocytes is associated with insulin resistance and type 2 diabetes. Diabetes-
associated anemia has been reported due to the increased non-enzymatic glycosylation of 
RBC membrane proteins, which correlates with hyperglycemia. The present study was hy-
pothesized to assess the effect of citrus flavonoids on hematological parameters and adipose 
tissue interleukin-6 and adiponectin in type 2 diabetic rats. Diabetes was induced by feeding 
rats with a high fat diet for 2 weeks followed by an intraperitoneal injection of streptozotocin. 
An oral dose of 50 mg/kg hesperidin or naringin was daily given for 4 weeks after diabetes 
induction. By the end of the experiment, blood samples were collected and were immediately 
used for determination of haematological parameters. Expression levels of adiponectin and in-
terleukin-6 were assayed in adipose tissue samples. Both hesperidin and naringin significantly 
improved the levels of erythrocytes, leukocytes and their functional indices. Similarly, sup-
plementation with either compound significantly ameliorated the declined adipose tissue adi-
ponectin expression in conjunction with down-regulated interleukin-6. The findings of the 
present study indicated that hesperidin and naringin exert protection to diabetes-associated 
anemia in type 2 diabetic rats. This could be due to attenuation of proinflammatory cytokine 
production and stimulation of adiponectin expression. 
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INTRODUCTION 
Diabetes mellitus (DM) is a complex 
metabolic disorder involving many organs 
and can devastate the lives of affected indi-
viduals (Khuwaja et al., 2010). It is charac-
terized with chronic high blood glucose that 
could lead to morbidity and mortality (Mo-
hammed et al., 2007). The number of peo-
ple suffering from diabetes worldwide is 
increasing at an alarming rate. It is predict-
ed that about 366 million people are likely 
to be diabetic by the year 2030 (Wild et al., 
2004). 
The adipokines are signaling proteins 
involved in the regulation of energy and 
glucose metabolism (Wild et al., 2004). Ad-
ipocytes secrete diverse pro-inflammatory 
cytokines such as interleukin (IL)-6 and 
tumor necrosis factor (TNF)-α, as well as 
anti-inflammatory cytokines such as adi-
ponectin (Kershaw and Flier, 2004). Dys-
function in adipocytes or adipose tissue is 
associated with insulin resistance and type 
2 diabetes (Sowers, 2008). A reduced level 
of adiponectin and increased levels of IL-6 
and TNF-α can induce or exacerbate insulin 
resistance in adipose tissue (Blüher, 2009). 
Flavonoids are non-nutritive dietary 
components that are widely distributed in 
plants (Mahmoud, 2012). Naringin (4´,5,7- 
trihydroxy flavonone 7-rhamnoglucoside) is 
the predominant flavonone found in grape 
fruit and related citrus species (Jagetia and 
EXCLI Journal 2013;12:647-657 – ISSN 1611-2156 
Received: March 25, 2013, accepted: July 10, 2013, published: July 19, 2013 
 
 
648 
Reddy, 2002). Among the naturally occur-
ring flavonoids, naringin has been empiri-
cally proven to have no side effects, as hu-
mans have been ingesting grapes and citrus 
fruits for a long time (Choe et al., 2001). 
Hesperidin is an abundant and inexpensive 
byproduct of Citrus cultivation and isolated 
from the ordinary orange Citrus aurantium 
and other species of the genus Citrus (fami-
ly: Rutaceae) (Kakadiya et al., 2010). Re-
cently, we have reported the anti-diabetic 
potentials of both hesperidin and naringin 
in high fat diet/streptozotocin induced dia-
betic rats (Ahmed et al., 2012; Mahmoud et 
al., 2012, 2013). 
It has been reported that, ingestion of 
medicinal plants or drugs can alter the nor-
mal hematological values (Ajagbonna et al., 
1999). Therefore, hematological parameters 
could be an important tool in the assess-
ment of deleterious effect of drugs, as well 
as medicinal plants (Yakubu et al., 2007). 
Mansi and Lahham (2008) revealed that 
various hematological parameters and the 
immune system were reported to be altered 
during the course of diabetes. Thus, the in-
tention of the present study was to scruti-
nize the influence of oral administration of 
hesperidin and naringin on the levels of 
hematological parameters and adipose tis-
sue IL-6 and adiponectin in type 2 diabetic 
rats 
 
MATERIALS AND METHODS 
Chemicals 
Hesperidin, naringin and streptozotocin, 
were purchased from Sigma Chemicals Co., 
St. Louis, MO, USA, stored at 2–4 °C and 
protected from sunlight. All other chemi-
cals were of analytical grade and were ob-
tained from standard commercial supplies. 
 
Experimental animals 
White male albino rats (Rattus norvegi-
cus) weighing about 130–150 g were used. 
They were obtained from the animal house 
of the National Research Center, El- Giza, 
Egypt. They were kept under observation 
for about 15 days before the onset of the 
experiment to exclude any intercurrent in-
fection. The chosen animals were housed in 
plastic well aerated cages at normal atmos-
pheric temperature (25 ± 5 °C) and normal 
12 hour light/dark cycle. Moreover, they 
had free access to water and were supplied 
daily with standard diet of known composi-
tion ad libitum. All animal procedures were 
in accordance with the recommendations of 
the Canadian Committee for Care and Use 
of Animals (Canadian Council on Animal 
Care, 1993). 
 
Induction of diabetes mellitus 
Type 2 DM was experimentally induced 
by feeding a high fat diet (HFD) for an ini-
tial period of 2 weeks followed by an intra-
peritoneal injection of 35 mg/kg b.wt strep-
tozotocin dissolved in citrate buffer pH 4.5 
(Srinivasan et al., 2005). Seven days after 
the injection, rats were screened for serum 
glucose levels. Rats having serum glucose 
≥ 200 mg/dl, after 2 hours of glucose in-
take, were considered diabetic and selected 
for further pharmacological studies. The 
rats were allowed to continue to feed on 
their respective diets until the end of the 
study. 
 
Experimental design 
The experimental animals were divided 
into four groups, each group comprising six 
rats as detailed follows. 
Group 1: Normal control rats (Fed normal 
fat diet) 
Group 2: Diabetic control rats 
Group 3: Diabetic rats administered with 
hesperidin (50 mg/kg b.wt.) oral-
ly for 4 weeks 
Group 4: Diabetic rats administered with 
naringin (50 mg/kg b.wt.) orally 
for 4 weeks. 
The dosage was adjusted every week 
according to any change in body weight to 
maintain similar dose per kg body weight of 
rat over the entire period of study for each 
group. By the end of the experiment, ani-
mals were sacrificed and blood samples and 
adipose tissue were obtained. 
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Haematological estimations 
The blood samples were collected into 
tubes containing EDTA and were immedi-
ately used for determination of haematolog-
ical parameters. Total red blood cell (RBC) 
and white blood cell (WBC) counts were 
estimated according to the visual method of 
Dacie and Lewis (1991). The percentage 
packed cell volume (PCV) was determined 
according to the hematocrit method (Alex-
ander and Grifiths, 1993) while the blood 
haemoglobin (Hb) concentration in all sam-
ples was estimated according to the cyano-
methaemoglobin method using Drabkin’s 
reagent (Alexander and Grifiths, 
1993).Mean cell volume (MCV), mean cor-
puscular hemoglobin (MCH) and mean 
corpuscular hemoglobin concentration 
(MCHC) were calculated as outlined in 
Dacie and Lewis (1991). Differential white 
blood cell counts were estimated using the 
method of Osim et al. (2004). 
 
RNA isolation and reverse transcriptase 
ploymerase chain reaction (RT-PCR) 
Total RNA was isolated from visceral 
adipose tissue using total RNA isolation kit 
(Fermentas, USA). First strand of cDNA 
was synthesized from 5 µg of total RNA by 
using a high-capacity cDNA reverse tran-
scription kit with RNase inhibitor (Applied 
Biosystems, USA). The produced cDNA 
was amplified using Green master mix 
(Fermentas, USA) using the following sets 
of primers: 
Adiponectin 
Up 5′-AATCCTGCCCAGTCATGAAG-3′ 
Down 5′-TCTCCAGGAGTGCCATCTCT-3′ 
IL-6 
Up  
5′-CTTCCAGCCAGTTGCCTTCT-3′ 
Down  
5′-GACAGCATTGGAAGTTGGGG-3′ 
β-actin 
Up  
5′-AAGTCCCTCACCCTCCCAAAAG-3′ 
Down  
5′-AAGCAATGCTGTCACCTTCCC-3′ 
The reaction tubes were placed on a 
double heated led thermal cycler and the re-
action series was performed as follows: ini-
tial denaturation at 95 °C for 2 min, then 35 
cycles each was 95 °C (30 s), 59.5 °C 
(30 s), 72 °C (45 s). 
PCR products were loaded in 1.5 % 
agarose gel (Sigma) and electrical power 
was applied then the samples were left to 
migrate for suitable time. After migration, 
the cDNA bands were observed in the gel 
using UV transilluminator. Gel images 
were analyzed by scanning densitometry 
(ImageJ, NIH) and values were normalized 
to the quantity of β-actin, and presented as 
% mRNA relative to control. 
 
Statistical analyses 
Statistical analysis was performed using 
SPSS v.16. Results were articulated as 
mean ± SE and all statistical comparisons 
were made by means of one-way ANOVA 
test followed by Duncan’s multiple range 
test post hoc analysis. A P value < 0.05 was 
considered significant. 
 
RESULTS 
RBC count of diabetic control rats 
(5.75 ± 0.21 x 106/µl) showed a significant 
decrease (P < 0.05) as compared to normal 
control rats (7.09 ± 0.15 x 106/µl). Both 
treatment agents showed a detectable ame-
lioration of RBC count of diabetic rats; the 
recorded values were 6.64 ± 0.65 and 
6.52 ± 0.26 x 106/µl for hesperidin and nar-
ingin respectively (Table 1). 
The recorded values of diabetic rats 
showed a notable (P < 0.01) decrease in 
blood hemoglobin content (10.17 ± 
0.08 g/dl) as compared with the normal 
control rats (15.33 ± 0.68 g/dl). Treatment 
with hesperidin and naringin produced a 
highly significant increase of the lowered 
blood hemoglobin content of diabetic rats; 
the values being 14.48 ± 0.62 and 14.33 ± 
0.49 g/dl, respectively (Table 1). 
The significant decrease in the levels of 
PCV, MCH, MCV and MCHC observed in 
the diabetic animals was drastically in-
EXCLI Journal 2013;12:647-657 – ISSN 1611-2156 
Received: March 25, 2013, accepted: July 10, 2013, published: July 19, 2013 
 
 
650 
creased to near normal level following hes-
peridin and naringin administration. 
Concerning white blood cell count the 
present data showed a significant increase 
(P < 0.05) in diabetic group when compared 
with control group (Table 2). Diabetic 
group showed non-significant change 
(P > 0.05) in the percentage of eosinophils, 
however, there was a significant increase 
(P < 0.01) in neutrophils, monocytes and 
basophils. On the other hand, lymphocytes 
showed a significant decrease (P < 0.01) 
when compared with normal control group 
throughout the experimental period. Both 
hesperidin and naringin supplementation 
significantly reversed these parameters.  
Densitometric analysis revealed a sig-
nificant (P < 0.01) increase of adipose tis-
sue IL-6 mRNA expression in HFD/STZ 
diabetic rats as compared with the normal 
control group. The treatment of the diabetic 
animals with either hesperidin or naringin 
significantly (P < 0.01) lowered the elevat-
ed IL-6 mRNA expression (Figure 1). Hes-
peridin seemed to be more potent than nar-
ingin in decreasing the adipose IL-6 expres-
sion. 
Adipose tissue adiponectin expression 
exhibited a different behavioral pattern 
where it was significantly (P < 0.01) de-
pressed as a result of STZ administration 
following the HFD. Both hesperidin and 
naringin supplementations produced a high-
ly significant (P < 0.01) amelioration of the 
depressed adipose tissue adiponectin 
mRNA content (Figure 2). 
 
 
Table 1: Effect of hesperidin and naringin on RBCs and related indices 
Parameters Normal Diabetic  Control 
Diabetic +  
Hesperidin 
Diabetic +  
Naringin F-Prob 
RBCs (x 106/µl) 7.09 ± 0.15a 5.75 ± 0.21b 6.64 ± 0.65ab 6.52 ± 0.26ab P<0.05 
Hb (g/dl) 15.33 ± 0.68a 10.17 ± 0.08b 14.48 ± 0.62a 14.33 ± 0.49a P<0.01 
PCV % 50.85 ± 1.83a 33.52 ± 4.23b 48.24 ± 1.29a 47.07 ± 1.31a P<0.01 
MCV (fl) 71.71 ± 1.12a 58.18 ± 5.35b 73.07 ± 5.81a 72.31 ± 4.46a P<0.05 
MCH (pg) 21.62 ± 0.54a 17.70 ± 0.70b 22.03 ± 1.47a 22.02 ± 3.12a P<0.05 
MCHC % 30.14 ± 0.57a 27.35 ± 2.13b 30.48 ± 2.08a 30.06 ± 1.46a P<0.05 
Data are expressed as mean ± SE. Number of animals in each group is six. 
Means which share the same superscript symbol(s) are not significantly different. 
 
Table 2: Effect of hesperidin and naringin on WBCs and differentials 
Parameters Normal Diabetic  Control 
Diabetic +  
Hesperidin 
Diabetic +  
Naringin F-Prob 
WBCs (x 103/µl) 7.53 ± 0.98a 11.03 ± 1.16b 7.65 ± 0.47a 7.37 ± 0.71a P<0.05 
Neutrophils % 45.42 ± 0.68a 53.24 ± 0.08b 41.93 ± 0.62a 46.02 ± 0.49a P<0.01 
Lymphocytes % 48.33 ± 1.83a 38.81 ± 4.23b 51.49 ± 1.29a 47.85 ± 1.31a P<0.01 
Monocytes % 4.17 ± 0.29a 5.50 ± 0.35b 4.54 ± 0.37a 4.13 ± 0.15a P<0.01 
Esinophils % 2.06 ± 0.50a 1.11 ± 0.64a 2.03 ± 0.71a 1.99 ± 0.93a P>0.05 
Basophils % 0.00 ± 0.00a 1.33 ± 0.57b 0.00 ± 0.00a 0.00 ± 0.00a P<0.05 
Data are expressed as mean ± SE. Number of animals in each group is six. 
Means which share the same superscript symbol(s) are not significantly different.
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Figure 1: RT-PCR analysis of adipose tissue 
IL-6 and β-actin expression of normal, diabetic 
control and diabetic rats treated with hesperidin 
and naringin. 
Top: Gel photograph depicting representative 
IL-6 and β-actin PCR products. 
Bottom: Corresponding densitometric analysis 
of adipose IL-6 PCR products from 3 different 
experiments, represented as the IL-6 band in-
tensity relative to β-actin. 
 
 
 
Figure 2: RT-PCR analysis of adipose tissue 
adiponectin and β-actin expression of normal, 
diabetic control and diabetic rats treated with 
hesperidin and naringin. 
Top: Gel photograph depicting representative 
adiponectin and β-actin PCR products. 
Bottom: Corresponding densitometric analysis 
of adipose adiponectin PCR products from 3 
different experiments, represented as the adi-
ponectin band intensity relative to β-actin. 
 
DISCUSSION 
The link between chronic diseases and 
anemia is well characterized (Weiss and 
Goodnough, 2005). The occurrence of 
anaemia in diabetes mellitus has been re-
ported due to the increased non-enzymatic 
glycosylation of RBC membrane proteins, 
which correlates with hyperglycemia 
(Oyedemi et al., 2011). Oxidation of these 
proteins and hyperglycaemia in diabetes 
mellitus causes an increase in the produc-
tion of lipid peroxides that lead to haemoly-
sis of RBC (Arun and Ramesh, 2002). The 
major pathological consequences of free 
radical induced membrane lipid peroxida-
tion include increased membrane rigidity, 
decreased cellular deformability, reduced 
erythrocyte survival, and lipid fluidity (Ko-
lanjiappan et al., 2002). In this study, the 
RBC membrane lipid peroxide levels in di-
abetic rats were not measured. However, 
RBC parameters such as Hb, MCHC, 
MCH, PCV and MCV were studied to inve-
 
 
stigate the effect of hesperidin and naringin 
on the anemic status. The decrease in MCH 
and MCHC values, observed after admin-
istration of STZ, is an indication of abnor-
mal hemoglobin synthesis, failure of blood 
osmoregulation, and plasma osmolarity 
(Stookey et al., 2007). 
Following hesperidin and naringin ad-
ministration, the level of RBCs and its re-
lated indices were appreciably improved. 
This gives an indication that both flavo-
noids can stimulate the formation or secre-
tion of erythropoietin, which stimulates 
stem cells in the bone marrow to produce 
red blood cells (Ohlsson and Aher, 2012). 
The stimulation of this hormone enhances 
rapid synthesis of RBC which is supported 
by the improved level of MCH and MCHC 
(Abu-Zaiton, 2010). These parameters are 
used mathematically to define the concen-
tration of haemoglobin and to suggest the 
restoration of oxygen carrying capacity of 
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the blood. We have previously reported that 
the action mechanism of both flavonoids 
may be attributed to their ability to lower 
lipid peroxidation level (Mahmoud et al., 
2012) that causes haemolysis of erythro-
cytes. 
The expression of hepcidin, a 25 amino 
acid peptide hormone, in the liver is in-
creased dramatically by inflammation and 
because of chronic disease (Nicolas et al., 
2002). Proinflammatory cytokines, such as 
IL-6 and IL-1 (Nemeth et al., 2004a; Lee et 
al., 2004a), are thought to be central to this 
mechanism. IL-6 in particular has been 
shown to exert its effects on hepcidin gene 
transcription via Janus kinase (JAK)/signal 
transducer and activator of transcription 
(STAT)3 interactions (Wrighting and An-
drews, 2006; Verga et al., 2007), which are 
essential to cytokine receptor signaling 
(Murray, 2007). Once released, hepcidin is 
thought to bind to the iron efflux protein 
ferroportin (Nemeth et al., 2004b) and 
thereby act as a negative regulator of body 
iron homeostasis, inhibiting the release of 
iron recycled from senescent red blood cells 
by reticuloendothelial macrophages (Knut-
son et al., 2005) and the absorption of die-
tary iron by intestinal enterocytes (Laftah et 
al., 2004). Moreover, it has been reported 
that in obese subjects the presence of chron-
ic low-grade inflammation, that resulted 
from the enhanced production and release 
of a cocktail of proinflammatory cytokines 
and adipokines from the adipose tissue 
(Lago et al., 2007)  lead to an increase in 
the expression of hepcidin (Knutson et al., 
2005). Thus, by attenuating pro-
inflammatory cytokines production 
(Mahmoud et al., 2012), hesperidin and nar-
ingin may participate directly to the amelio-
ration or RBC indices and correction of the 
anemic status in type 2 diabetic rats.  
Peripheral WBC count has been shown 
to be associated with insulin resistance, 
type 2 diabetes (Ohshita et al., 2004), coro-
nary artery disease (Lee et al., 2001), stroke 
(Lee et al., 2001), and diabetes micro- and 
macrovascular complications (Tong et al., 
2004). Peripheral blood leukocytes are 
composed of polymorphonuclear cells, in-
cluding monocytes as well as lymphocytes. 
Polymorpho- and mononuclear leukocytes 
can be activated by advanced glycation end 
products (Pertynska-Marczewska et al., 
2004), oxidative stress (Shurtz-Swirski et 
al., 2004), angiotensin II (Lee et al., 2004b), 
and cytokines (Scherberich, 2003) in a state 
of hyperglycemia. 
Leukocytes may be activated through 
the release of cytokines, such as TNF-α 
(Shanmugam et al., 2003), transforming 
growth factor-1 (Korpinen et al., 2001), su-
peroxide (Kedziora-Kornatowska, 1999), 
nuclear factor κB (NF-κB) (Hofmann et al., 
1998), monocyte chemoattractant protein 1, 
interleukin-1β, and others (Shanmugam et 
al., 2003) to participate in the pathogenesis 
of diabetic micro- and macrovascular com-
plications. The profile of the WBC count 
reflects the balance between the rate of 
granulocyte production and that of WBC. 
Kozlov et al. (1995) reported that diabetes 
in mice was accompanied by moderate neu-
trophilic leukocytosis and prolonged circu-
lation times of neutrophils and monocytes, 
and a shortened circulation time of lympho-
cytes, which increases the susceptibility to 
infection. The raised leukocyte count may 
also reflect low-grade inflammation. 
The mechanism responsible for leuko-
cytosis in obesity, diabetes, or atherosclero-
sis is largely unknown. Recent evidence 
suggests that leptin and the leptin receptor 
are parts of a pathway that stimulates he-
mopoiesis (Peelman et al., 2004). Leptin re-
ceptors exhibit structural similarity to class 
I cytokine receptors (Frühbeck, 2006). In-
terestingly, this class of receptors also in-
cludes the gp130 subunit of the IL-6 recep-
tor family, suggesting that IL-6 and leptin 
may operate via a similar mode of action 
(Baumann et al., 1996). This may explains 
the raised leukocyte count in conjunction 
with reported elevation in serum IL-6 and 
adipose tissue IL-6 mRNA expression. The 
decrease in the WBC count, in diabetic 
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treated rats shows the anti-inflammatory 
property of both hesperidin and naringin. 
The commonly used marker for total 
body iron stores, serum ferritin, is respon-
sive to inflammatory stress (De Domenico 
et al., 2008), so increased ferritin in diabe-
tes could simply reflect the inflammatory 
component of that disease (Hotamisligil, 
2006). Recent studies have found a negative 
correlation between serum ferritin and the 
insulin-sensitizing adipokine, adiponectin 
(Fargnoli et al., 2008; Ku et al., 2009). The 
hypothesis that adiponectin links iron and 
insulin resistance is appealing, as decreased 
adiponectin levels are associated with obe-
sity and type 2 diabetes (Weyer et al., 2001) 
and are causally linked with insulin re-
sistance (Kubota et al., 2002). Our results 
showed a decreased expression of adipose 
tissue adiponectin mRNA expression which 
coincides with anemia. Administration of 
hesperidin as well as naringin potentially 
ameliorated the depressed adiponectin 
which may partially explain the alleviation 
in the hematological parameters in diabetic 
rats. 
Thus, the present study revealed that 
both hesperidin and naringin could protect 
form diabetes associated anemia via their 
effects on the adipose tissue through atten-
uating the pro-inflammatory cytokine pro-
duction and enhancement of adiponectin 
expression. 
 
CONCLUSION 
The findings of the present study indi-
cate that hesperidin and naringin exert pro-
tection to diabetes-associated anemia in 
HFD/STZ diabetic rats. This could be due 
to the prevention or inhibition of lipid pe-
roxidative system by their antioxidant and 
maintenance of cellular integrity, attenua-
tion of proinflammatory cytokine produc-
tion and stimulation of adiponectin expres-
sion. Moreover, the results suggest that 
both hesperidin and naringin are safe and 
capable of normalizing hematological ab-
normalities associated with diabetes melli-
tus thus could be prescribed as adjunct to 
dietary therapy and main therapy for diabe-
tes mellitus. 
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